Primoris Wealth Advisors’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.61M Sell
139,200
-200
-0.1% -$6.5K 3.23% 9
2025
Q4
$4.56M Sell
139,400
-3,660
-3% -$90K 2.73% 12
2025
Q3
$2.55M Buy
143,060
+127,360
+811% +$1.85M 1.62% 21
2025
Q2
$170K Buy
15,700
+1,300
+9% +$17K 0.12% 96
2025
Q1
$277K Hold
14,400
0.21% 78
2024
Q4
$237K Sell
14,400
-350
-2% -$4.96K 0.18% 82
2024
Q3
$207K Buy
+14,750
New +$163K 0.15% 97

Other funds holding AXGN

Primoris Wealth Advisors's AXGN Position: Q1 2026 in Review

Primoris Wealth Advisors reduced its Axogen (AXGN) stake by 0.14% in Q1 2026, selling an estimated $6.5K and leaving 139,200 shares worth $4.61M. The position accounts for 3.23% of the portfolio, ranked #9.

Primoris Wealth Advisors first reported a position in AXGN in Q3 2024 and has held it in 7 quarters since. 220 funds tracked by Wall St. Rank hold AXGN as of Q1 2026.

  • Primoris Wealth Advisors held 139,200 shares of Axogen worth $4.61M as of Q1 2026.
  • Primoris Wealth Advisors sold 200 Axogen shares in Q1 2026, an estimated $6.5K.
  • Axogen made up 3.23% of Primoris Wealth Advisors's portfolio in Q1 2026, its #9 holding.
  • Primoris Wealth Advisors first reported a position in Axogen in Q3 2024 and has held it in 7 quarters since.
  • 220 funds tracked by Wall St. Rank held Axogen as of Q1 2026.

Based on Primoris Wealth Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.